mjhassoc.com
Managed Market Group
http://www.mjhassoc.com/group/managed-market-group
Michael J. Hennessy and Associates, Inc. Our Companies and Offerings. HRA - Healthcare Research and Analytics. Last Updated On: April 18, 2016. A Leader in Managed Markets. Founded in 1995,. The American Journal of Managed Care. Is a peer-reviewed, indexed journal dedicated to publishing original healthcare outcomes research. The journal. S influence is seen in the frequency with which authors and their articles are referenced in national media outlets. Launched in 2009,. Circulate to individuals with im...
mjhassoc.com
Pharmacy Times Office of Continuing Professional Education
http://www.mjhassoc.com/group/pharmacy-times-office-of-continuing-professional-education
Michael J. Hennessy and Associates, Inc. Our Companies and Offerings. HRA - Healthcare Research and Analytics. Last Updated On: May 03, 2016. Pharmacy Times Office of Continuing Professional Education. PTOCPE’s mission is to provide accredited activities that:. Contain fair and balanced, evidence-based clinical information for pharmacists so that they may be the primary resource for unbiased information and advice regarding the safe, appropriate, and cost-effective use of medications. These accredited ac...
mjhassoc.com
Pharmacy Group
http://www.mjhassoc.com/group/pharmacy-group
Michael J. Hennessy and Associates, Inc. Our Companies and Offerings. HRA - Healthcare Research and Analytics. Last Updated On: August 16, 2016. Where Pharmacists Turn for Information. Our franchise was founded in 1897, and through our coordinated and integrated approach, we make it easy for our clients to achieve the optimal message frequency to achieve brand recognition and message retention. The editorial mission is to bring practical information to the practicing pharmacist with timely and essential ...
mjhassoc.com
Consumer Health
http://www.mjhassoc.com/group/consumer-health
Michael J. Hennessy and Associates, Inc. Our Companies and Offerings. HRA - Healthcare Research and Analytics. Last Updated On: May 03, 2016. Magazine is the indispensable guide to every stage of the cancer experience. With nearly 1 million readers,. Is the largest consumer magazine in the United States focused entirely on cancer, with broad distribution to cancer patients, cancer centers, and advocacy groups. Feature and Exclusive Articles. Sthma to the role of Z. Inc, written specifically for patients ...
hornercom.com
U.S. News & World Report and Pharmacy Times Announce the 2015 Top Recommended Health Products
http://www.hornercom.com/News/NewsDetail/TabId/201/dt/HornerNewsDetail/ItemID/166/US-News-World-Report-and-Pharmacy-Times-Announce-the-2015-Top-Recommended-Health-Products-.aspx
Open Positions - Copy. Public Relations Account Supervisor. Open Positions - Copy. Public Relations Account Supervisor. 06/16/2015 - Client News. US News and World Report and Pharmacy Times Announce the 2015 Top Recommended Health Products. New No.1 Pharmacist Recommended Brands Added for Mom and Baby. Washington, D.C. – June 16, 2015 –. And www.otcguide.net. To see the collective recommendations of thousands of pharmacists for more than 1,100 over-the-counter brands and 168 product categories. This year...
hcplive.com
How to Improve Medical Practice Profitability | MD Magazine
http://www.hcplive.com/physicians-money-digest/blogs/financial-health-check-up/03-2014/How-to-Improve-Medical-Practice-Profitability
Every individual needs regular physical health check ups. Likewise, physicians and medical practices need to consider financial health check ups. To accomplish the latter, the Financial Health Check Up column provides physicians with pertinent, useful news and information from both a personal and practice management perspective. How to Improve Medical Practice Profitability. Mar 03, 2014. Financial Health Check Up. How many of them can the practice get to come into its fold? White says that one of the fi...
ajmc.com
Newsroom | AJMC
http://www.ajmc.com/articles/Questioning-the-Widely-Publicized-Savings-Reported-for-North-Carolina-Medicaid
American Heart Association Calls for Sharp Limits on Sugar for Kids. August 23, 2016. The recommendation comes after a review of evidence of how sugar consumption affects children's health. FDA is scheduled to add information on added sugar to food labels in 2018. The Final Word Is Out: Menopausal HRT Triples the Risk of Breast Cancer. August 23, 2016. What We're Reading: GOP May Work to Fix, Not Repeal, ACA Under New President. August 23, 2016. August 22, 2016. FDA Deals Sanofi a Setback in Combo Battle.
hcplive.com
Investing | MD Magazine
http://www.hcplive.com/physicians-money-digest/investing
30 Day Mindful Financial Practice with Dr. Wise Money. Aug 25, 2016. CONTRIBUTOR Dr. Wise Money. I've seen and heard about so many inspirational 30-day challenges all over the media, including Facebook, Family Life Radio, even on Pandora. After a decade of physical inactivity, I recently completed the 30-Day Yoga challenge with Adrienne. I feel great! I will continue my yoga practice with more free YouTube videos. The Facts About Non-Clinical Jobs. Aug 24, 2016. CONTRIBUTOR Heidi Moawad, MD. Aug 23, 2016.
hcplive.com
Hospital Medicine | MD Magazine
http://www.hcplive.com/specialty/hospital-medicine
The MD Magazine Hospital Medicine specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content. Wet Age-Related Macular Degeneration/Diabetic Macular Edema. 2015 American College of Cardiology Annual Scientific Session and Expo. 2015 American Medical Association Annual Meeting. 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers. 2015 Conference on Retroviruses and Opportunistic Infections.
hcplive.com
Segment 8: Alemtuzumab Induction Therapy for MS | MD Magazine
http://www.hcplive.com/insights/multiple-sclerosis/Segment-8-Alemtuzumab-Induction-Therapy-for-MS
Segment 8: Alemtuzumab Induction Therapy for MS. Apr 24, 2015. Coyle describes the challenges alemtuzumab faced before receiving FDA approval. Though pivotal phase 3 trials clearly demonstrated its efficacy in relapsing MS, the FDA turned down alemtuzumab twice based on concerns related to trial designs—the trials were not double-blinded. The company eventually addressed the concerns of the FDA, the application was resubmitted, and approval was granted in November 2014. Patricia K. Coyle, MD, profess...
SOCIAL ENGAGEMENT